AD	Alzheimer’s disease
Aβ	amyloid-β
PTMs	post-translational modifications,
LC-MS/MS	liquid chromatography-tandem mass spectrometry
PEA	proximity extension assay
FTD	frontotemporal dementia
SWATH-MS	Sequential window acquisition of all theoretical mass spectra
CSF	Cerebrospinal fluid
(AT(N))	Amyloid-tau-neurodegeneration
DMN	Default mode network (DMN)
AR	Androgen receptor (AR)
PET	Positron emission tomography
MCI	Mild cognitive impairment
SCD	Subjective cognitive decline
TMT-MS	tandem mass tag mass spectrometry
ADNI	Alzheimer’s Disease Neuroimaging Initiative
Simoa	Single Molecule array
NFT	Neurofibrillary tangles